Seyfarth Shaw, a national firm with historic labor and employment law roots, has charted an expansion into intellectual property law in Washington through the acquisition of Fanelli Haag, a boutique whose partners won big last year after it sold a cancer vaccine it partially owned.
The acquisition moves two partners, Dean Fanelli and Thomas Haag, two counsel attorneys and two patent agents into Seyfarth’s litigation department.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
